Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 21.23 CNY -0.66%
Market Cap: 60.5B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

9.6
Current
7.7
Median
17.6
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
9.6
=
Enterprise Value
80.7B CNY
/
EBIT
8.5B CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
8.1
2-Years Forward
EV/EBIT
7.3
3-Years Forward
EV/EBIT
6.6

See Also

Discover More